US Stock MarketDetailed Quotes

APLT Applied Therapeutics

Watchlist
  • 0.853
  • -0.033-3.76%
Close Dec 27 16:00 ET
  • 0.876
  • +0.023+2.71%
Post 19:25 ET
99.29MMarket Cap-0.60P/E (TTM)

Applied Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-58.43%-23.33M
-37.34%-22.6M
-170.54%-18.91M
29.35%-55.17M
-7.00%-17.01M
24.05%-14.73M
10.59%-16.45M
71.36%-6.99M
13.93%-78.09M
41.01%-15.89M
Net income from continuing operations
-61.89%-68.59M
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
-121.82%-42.37M
-14.39%-29.58M
56.16%-10.14M
21.86%-82.51M
46.87%-14.43M
Operating gains losses
47.33%40.19M
-277.64%-22.75M
13,619.19%63.41M
85,616.67%56.57M
498.64%16.96M
5,818.24%27.28M
193.87%12.8M
-206.35%-469K
--66K
---4.26M
Depreciation and amortization
-11.86%104K
5.17%122K
5.26%120K
-20.09%354K
-94.74%6K
6.31%118K
5.45%116K
5.56%114K
6.75%443K
7.55%114K
Other non cash items
13.22%-105K
42.08%-512K
-59.94%260K
-44.58%1.74M
-39.55%2.1M
-9.01%-121K
26.52%-884K
-34.25%649K
878.96%3.15M
3,408.57%3.47M
Change In working capital
261.06%2.99M
-130.56%-4.81M
-242.48%-1.14M
83.71%-1.44M
15,381.82%1.7M
52.35%-1.85M
-3,267.74%-2.09M
116.28%798K
-1,340.39%-8.84M
100.29%11K
-Change in prepaid assets
-67.91%-361K
-1,301.23%-1.14M
-73.37%-319K
421.45%1.87M
278.74%2.35M
-182.06%-215K
-108.89%-81K
87.18%-184K
121.70%359K
213.53%621K
-Change in payables and accrued expense
295.96%3.35M
-570.13%-3.68M
-106.47%-59K
68.58%-2.06M
33.24%-717K
58.87%-1.71M
-125.75%-549K
126.31%912K
-219.85%-6.56M
66.48%-1.07M
-Change in other current liabilities
--0
--0
-1,184.29%-759K
-36.42%295K
-85.34%68K
--69K
--88K
--70K
--464K
--464K
-Change in other working capital
----
----
----
50.21%-1.55M
--0
--0
----
----
29.99%-3.11M
--0
Cash from discontinued investing activities
Operating cash flow
-58.43%-23.33M
-37.34%-22.6M
-170.54%-18.91M
29.35%-55.17M
-7.00%-17.01M
24.05%-14.73M
10.59%-16.45M
71.36%-6.99M
13.93%-78.09M
41.01%-15.89M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
5.33%13.87M
0
0
0
45.64%13.87M
5.93%13.17M
-158.48%-6.91M
Net investment purchase and sale
--0
--0
--0
5.33%13.87M
--0
--0
--0
45.64%13.87M
5.93%13.17M
-158.48%-6.91M
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
5.33%13.87M
--0
--0
--0
45.64%13.87M
5.93%13.17M
-158.48%-6.91M
Financing cash flow
Cash flow from continuing financing activities
0
-105.80%-1.69M
18,668.65%115.5M
169.18%74.54M
3,256.06%29.45M
1,806.18%16.57M
-4.06%29.15M
21.17%-622K
-62.94%27.69M
21.20%-933K
Net issuance payments of debt
--0
--0
50.00%-311K
43.23%-1.86M
50.16%-465K
50.11%-465K
50.57%-306K
21.17%-622K
30.63%-3.27M
21.20%-933K
Net common stock issuance
--0
-107.18%-2M
--106.75M
131.97%64.51M
--29.91M
7,731.82%6.72M
--27.89M
--0
-62.63%27.81M
--0
Proceeds from stock option exercised by employees
--0
1,376.19%310K
--9.06M
21,002.04%10.34M
--3K
20,953.06%10.32M
--21K
--0
-91.55%49K
--0
Net other financing activities
----
----
----
-50.21%1.55M
--0
--0
----
----
-29.97%3.11M
--0
Cash from discontinued financing activities
Financing cash flow
--0
-105.80%-1.69M
18,668.65%115.5M
169.18%74.54M
3,256.06%29.45M
1,806.18%16.57M
-4.06%29.15M
21.17%-622K
-62.94%27.69M
21.20%-933K
Net cash flow
Beginning cash position
243.10%122.2M
539.19%146.48M
199.56%49.9M
-69.09%16.66M
-7.26%37.46M
-36.09%35.62M
-40.03%22.92M
-69.09%16.66M
-6.23%53.89M
-42.47%40.39M
Current changes in cash
-1,367.25%-23.33M
-291.25%-24.29M
1,442.91%96.59M
189.28%33.24M
152.43%12.44M
112.00%1.84M
-27.49%12.7M
139.94%6.26M
-940.55%-37.23M
-45.42%-23.73M
End cash Position
163.95%98.87M
243.10%122.2M
539.19%146.48M
199.56%49.9M
199.56%49.9M
-7.26%37.46M
-36.09%35.62M
-40.03%22.92M
-69.09%16.66M
-69.09%16.66M
Free cash flow
-58.43%-23.33M
-37.34%-22.6M
-170.54%-18.91M
29.35%-55.17M
-7.00%-17.01M
24.05%-14.73M
10.59%-16.45M
71.36%-6.99M
13.93%-78.09M
41.01%-15.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -58.43%-23.33M-37.34%-22.6M-170.54%-18.91M29.35%-55.17M-7.00%-17.01M24.05%-14.73M10.59%-16.45M71.36%-6.99M13.93%-78.09M41.01%-15.89M
Net income from continuing operations -61.89%-68.59M109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M-121.82%-42.37M-14.39%-29.58M56.16%-10.14M21.86%-82.51M46.87%-14.43M
Operating gains losses 47.33%40.19M-277.64%-22.75M13,619.19%63.41M85,616.67%56.57M498.64%16.96M5,818.24%27.28M193.87%12.8M-206.35%-469K--66K---4.26M
Depreciation and amortization -11.86%104K5.17%122K5.26%120K-20.09%354K-94.74%6K6.31%118K5.45%116K5.56%114K6.75%443K7.55%114K
Other non cash items 13.22%-105K42.08%-512K-59.94%260K-44.58%1.74M-39.55%2.1M-9.01%-121K26.52%-884K-34.25%649K878.96%3.15M3,408.57%3.47M
Change In working capital 261.06%2.99M-130.56%-4.81M-242.48%-1.14M83.71%-1.44M15,381.82%1.7M52.35%-1.85M-3,267.74%-2.09M116.28%798K-1,340.39%-8.84M100.29%11K
-Change in prepaid assets -67.91%-361K-1,301.23%-1.14M-73.37%-319K421.45%1.87M278.74%2.35M-182.06%-215K-108.89%-81K87.18%-184K121.70%359K213.53%621K
-Change in payables and accrued expense 295.96%3.35M-570.13%-3.68M-106.47%-59K68.58%-2.06M33.24%-717K58.87%-1.71M-125.75%-549K126.31%912K-219.85%-6.56M66.48%-1.07M
-Change in other current liabilities --0--0-1,184.29%-759K-36.42%295K-85.34%68K--69K--88K--70K--464K--464K
-Change in other working capital ------------50.21%-1.55M--0--0--------29.99%-3.11M--0
Cash from discontinued investing activities
Operating cash flow -58.43%-23.33M-37.34%-22.6M-170.54%-18.91M29.35%-55.17M-7.00%-17.01M24.05%-14.73M10.59%-16.45M71.36%-6.99M13.93%-78.09M41.01%-15.89M
Investing cash flow
Cash flow from continuing investing activities 0005.33%13.87M00045.64%13.87M5.93%13.17M-158.48%-6.91M
Net investment purchase and sale --0--0--05.33%13.87M--0--0--045.64%13.87M5.93%13.17M-158.48%-6.91M
Cash from discontinued investing activities
Investing cash flow --0--0--05.33%13.87M--0--0--045.64%13.87M5.93%13.17M-158.48%-6.91M
Financing cash flow
Cash flow from continuing financing activities 0-105.80%-1.69M18,668.65%115.5M169.18%74.54M3,256.06%29.45M1,806.18%16.57M-4.06%29.15M21.17%-622K-62.94%27.69M21.20%-933K
Net issuance payments of debt --0--050.00%-311K43.23%-1.86M50.16%-465K50.11%-465K50.57%-306K21.17%-622K30.63%-3.27M21.20%-933K
Net common stock issuance --0-107.18%-2M--106.75M131.97%64.51M--29.91M7,731.82%6.72M--27.89M--0-62.63%27.81M--0
Proceeds from stock option exercised by employees --01,376.19%310K--9.06M21,002.04%10.34M--3K20,953.06%10.32M--21K--0-91.55%49K--0
Net other financing activities -------------50.21%1.55M--0--0---------29.97%3.11M--0
Cash from discontinued financing activities
Financing cash flow --0-105.80%-1.69M18,668.65%115.5M169.18%74.54M3,256.06%29.45M1,806.18%16.57M-4.06%29.15M21.17%-622K-62.94%27.69M21.20%-933K
Net cash flow
Beginning cash position 243.10%122.2M539.19%146.48M199.56%49.9M-69.09%16.66M-7.26%37.46M-36.09%35.62M-40.03%22.92M-69.09%16.66M-6.23%53.89M-42.47%40.39M
Current changes in cash -1,367.25%-23.33M-291.25%-24.29M1,442.91%96.59M189.28%33.24M152.43%12.44M112.00%1.84M-27.49%12.7M139.94%6.26M-940.55%-37.23M-45.42%-23.73M
End cash Position 163.95%98.87M243.10%122.2M539.19%146.48M199.56%49.9M199.56%49.9M-7.26%37.46M-36.09%35.62M-40.03%22.92M-69.09%16.66M-69.09%16.66M
Free cash flow -58.43%-23.33M-37.34%-22.6M-170.54%-18.91M29.35%-55.17M-7.00%-17.01M24.05%-14.73M10.59%-16.45M71.36%-6.99M13.93%-78.09M41.01%-15.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
0.00%
Petroleo Brasileiro SA Petrobras
PBR
-0.13%
Vale SA
VALE
-0.45%
Meta Platforms
META
-0.59%
Adobe
ADBE
-0.82%

Unlock the Full List